Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This will be a 12-week, multicenter, randomized, double-blind trial evaluating the efficacy,
safety, and tolerability of brexpiprazole + sertraline combination treatment in adult
subjects with Post-Traumatic Stress Disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.